LENZ Therapeutics Inc.
LENZ | NASDAQ
$4.08
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.08
$0 (0.00%)
Pre-market:
Sep 22, 2026, 5:02 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.61 | -12.34 | -0.81 | -1.22 | -6.89 | -10.63 |
PEG Ratio | -0.26 | 0.15 | -0.04 | -0.02 | -1.90 | 0 |
PS Ratio | 24.15 | n/a | n/a | 8.21 | n/a | n/a |
PB Ratio | 1.62 | 3.01 | -1.09 | -5.10 | -34.30 | -74.13 |
P/FCF Ratio | -6.59 | -10.26 | -1.67 | -1.30 | -8.32 | -70.77 |
P/OCF Ratio | -6.66 | -10.34 | -1.67 | -1.40 | -9.22 | -83.30 |
OCF/S Ratio | -362.37 | n/a | n/a | -586.53 | n/a | n/a |
Debt / Equity Ratio | 0 | 0.01 | 0 | -0.01 | n/a | n/a |
Quick Ratio | 14.23 | 20.36 | 3.63 | 4.91 | 14.62 | 0.66 |
Current Ratio | 14.23 | 20.36 | 3.63 | 4.91 | 14.62 | 0.66 |
Asset Turnover | 0.06 | n/a | n/a | 0.32 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -337.50 |
Return on Equity | -28.88% | -24.39% | 75.47% | 44.73% | 497.82% | 697.68% |
Return on Assets | -26.85% | -23.12% | -99.42% | -23.03% | -385.93% | -303.02% |
Return on Invested Capital | -31.96% | -28.53% | -138.93% | -27.91% | -353.84% | 142.34% |
Dividend Yield | n/a | 49.95% | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -616.59% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 96.31% | n/a | n/a | 100% | n/a | n/a |
Net Profit Margin | -430.25% | n/a | n/a | -72.07% | n/a | n/a |
Pretax Profit Margin | -427.62% | n/a | n/a | -69.76% | n/a | n/a |
Operating Profit Margin | -477.46% | n/a | n/a | -69.89% | n/a | n/a |
FCF Margin | -366.71% | n/a | n/a | -630.49% | n/a | n/a |
EBITDA Margin | -426.12% | n/a | n/a | -69.71% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove LENZ